+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of novel cytotoxic noncamptothecin topoisomerase I poisons



Identification of novel cytotoxic noncamptothecin topoisomerase I poisons



Proceedings of the American Association for Cancer Research Annual Meeting 44: 347




(PDF emailed within 1 workday: $29.90)

Accession: 035076740

Download citation: RISBibTeXText


Related references

Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons. Journal of Medicinal Chemistry 42(3): 446-457, 1999

Cytotoxic compounds from Annonaceus species as DNA topoisomerase I poisons. Anticancer Research 21(5): 3493-3497, 2002

Novel ametantrone-amsacrine related hybrids as topoisomerase II╬▓ poisons and cytotoxic agents. Archiv der Pharmazie 347(10): 728-737, 2015

The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives. Molecular Cancer Therapeutics 8(5): 1008-1014, 2011

Quantitative structure-activity relationship studies of 5-substituted terbenzimidazoles as topoisomerase I poisons and cytotoxic agents. Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 22, 1997

Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282. Molecular Cancer Therapeutics 10(8): 1490-1499, 2011

Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison. Molecular Pharmacology 54(1): 50-58, 1998

Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors. Journal of Medicinal Chemistry 56(18): 7458-7462, 2013

Characterization of two camptothecin-resistant human lines and a partial revertant with altered cytotoxic/cytostatic responses to topoisomerase poisons. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 331, 1993

Inhibitory Effect of the Noncamptothecin Topoisomerase I Inhibitor LMP-400 on Female Mice Models and Human Pheochromocytoma Cells. Endocrinology 156(11): 4094-4104, 2016

A Fluorescence-Based Assay for Identification of Bacterial Topoisomerase I Poisons. Methods in Molecular Biology 1703: 259-268, 2018

Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer. Cancer Research 75(19): 4176-4187, 2016

Identification of early gene expression changes in primary cultured neurons treated with topoisomerase I poisons. Biochemical and Biophysical Research Communications 479(2): 319-324, 2016

A mutation in yeast topoisomerase II that confers hypersensitivity to multiple classes of topoisomerase II poisons. Journal of Biological Chemistry 275(11): 7980-7987, 2000

Modulation of topoisomerase I and IIalpha levels in tumour cells upon exposure to topoisomerase poisons. British Journal of Cancer 80(SUPPL 2): 50, 1999